Evidence map›Paper›PMID 28394489›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2017

Cancer in Solid Organ Transplant Recipients: There Is Still Much to Learn and Do.

E A Engels

Abstract readEditorialComment
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Imaging of cystic fibrosis manifestations in the abdomen.Abdominal radiology (New York) · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. A Lesson of Immunosuppression in Renal Transplant: Retreat or Hold?The Yale journal of biology and medicine · 2023
    Observational
  12. Article
  13. Article
  14. Malignancy after lung transplantation.Annals of translational medicine · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

E A EngelsDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

Funding

Infections, immunity, and inflammation in cancerZIACP010150 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ENGELS, ERIC A · 2009 to 2025
$24.0M
Infections, immunity, and inflammation in cancerZ01CP010150 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ENGELS, ERIC A · 2000 to 2008
$3.0M
Intramural NIH HHS Z01 CP010150
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsNeoplasmsOrgan TransplantationHumansImmunosuppression TherapyTransplant RecipientsAntineoplastic Agentscancer/malignancy/neoplasiacomorbiditiesdisease pathogenesiseditorial/personal viewpointhematology/oncologyimmune deficiencyimmunosuppressantimmunosuppression/immune modulationtranslational research/science

Identifiers

PMID28394489
PMCPMC6309190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.